Inactive Instrument

Avantor, Inc. Stock Nyse

Equities

AVTR.PRA

US05352A2096

Medical Equipment, Supplies & Distribution

Sales 2024 * 6.93B Sales 2025 * 7.31B Capitalization 14.2B
Net income 2024 * 424M Net income 2025 * 621M EV / Sales 2024 * 2.72 x
Net Debt 2024 * 4.67B Net Debt 2025 * 3.91B EV / Sales 2025 * 2.48 x
P/E ratio 2024 *
31 x
P/E ratio 2025 *
22 x
Employees 14,500
Yield 2024 *
-
Yield 2025 *
-
Free-Float 96.68%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 51 14-04-30
Director of Finance/CFO 54 23-08-06
Compliance Officer - -
Members of the board TitleAgeSince
Director/Board Member 54 21-10-31
Director/Board Member 68 20-05-06
Chairman 66 17-03-31
More insiders
Avantor, Inc. is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education and government, and advanced technologies & applied materials industries. Its products include materials and consumables, equipment and instrumentation, and services and specialty procurement. Materials and consumables include chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits and education and microbiology and clinical trial kits. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, freezers, biological safety cabinets and critical environment supplies. Services and specialty procurement include onsite lab and production, clinical, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Calendar
More about the company